scholarly journals bZIP transmembrane transcription factor CREBH: Potential role in non-alcoholic fatty liver disease (Review)

2015 ◽  
Vol 13 (2) ◽  
pp. 1455-1462 ◽  
Author(s):  
MIN WANG ◽  
SHUIPING ZHAO ◽  
MINGYUE TAN
2020 ◽  
Vol 131 ◽  
pp. 110785
Author(s):  
Samukelisiwe C. Shabalala ◽  
Phiwayinkosi V. Dludla ◽  
Lawrence Mabasa ◽  
Abidemi P. Kappo ◽  
Albertus K. Basson ◽  
...  

2016 ◽  
Vol 150 (4) ◽  
pp. S1171-S1172
Author(s):  
Praveen Kumar Conjeevaram Selvakumar ◽  
Mohammad Nasser Kabbany ◽  
Rocio Lopez ◽  
Giulia Tozzi ◽  
Naim Alkhouri ◽  
...  

2016 ◽  
Vol 48 (8) ◽  
pp. 909-913 ◽  
Author(s):  
Praveen Kumar Conjeevaram Selvakumar ◽  
Mohammad Nasser Kabbany ◽  
Rocio Lopez ◽  
Giulia Tozzi ◽  
Anna Alisi ◽  
...  

PLoS Genetics ◽  
2014 ◽  
Vol 10 (5) ◽  
pp. e1004335 ◽  
Author(s):  
Deanna L. Howarth ◽  
Claudia Lindtner ◽  
Ana M. Vacaru ◽  
Ravi Sachidanandam ◽  
Orkhontuya Tsedensodnom ◽  
...  

Cells ◽  
2020 ◽  
Vol 9 (1) ◽  
pp. 184 ◽  
Author(s):  
Shiming Peng ◽  
Wei Li ◽  
Nannan Hou ◽  
Niu Huang

FoxO1 is a conserved transcription factor involved in energy metabolism. It is tightly regulated by modifications on its mRNA and protein and responds to environmental nutrient signals. FoxO1 controls the transcription of downstream genes mediating metabolic regulation. Dysfunction of FoxO1 pathways results in several metabolic diseases, including diabetes, obesity, non-alcoholic fatty liver disease, and atherosclerosis. Here, we summarize the mechanism of FoxO1 regulation behind these diseases and FoxO1-related drug discoveries.


2021 ◽  
Vol 1 (1) ◽  
pp. 33
Author(s):  
CS Gautam ◽  
Jatin Sharma ◽  
Mandeep Singla ◽  
Ilmjot Kaur Tiwana ◽  
Harmanjit Singh ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document